GI Pathogen Testing Market: Growth Patterns and Outlook
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Forecasted Market Size Trajectory Of The Gastrointestinal Pathogen Testing Market From 2026 To 2030?
The market for gastrointestinal pathogen testing has seen consistent expansion over recent years. It is anticipated to increase from $4.23 billion in 2025 to $4.41 billion by 2026, achieving a compound annual growth rate (CAGR) of 4.2%. The historical growth of the gastrointestinal pathogen testing market can be attributed to the widespread incidence of gastrointestinal infections, the adoption of culture-based testing methodologies, the expansion of hospital laboratories, occurrences of foodborne illness outbreaks, and the implementation of public health surveillance programs.
The gastrointestinal pathogen testing market size is projected to experience consistent expansion over the upcoming years. This market is anticipated to reach $5.06 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 3.5%. The projected growth is linked to factors such as an increase in syndromic testing panels, broader availability of point-of-care diagnostics, the need for quicker results, the incorporation of molecular diagnostics, and heightened awareness of infectious diseases. Key trends expected during this period involve a surge in the application of multiplex molecular diagnostic panels, a greater call for rapid stool tests, the proliferation of point-of-care GI diagnostics, an increasing uptake of PCR-based testing, and a stronger emphasis on monitoring infections.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Key Factors Are Driving The Gastrointestinal Pathogen Testing Market Growth?
The increasing occurrences of foodborne illnesses are anticipated to drive the expansion of the gastrointestinal pathogen testing market in the future. Foodborne diseases are ailments contracted from consuming contaminated food or beverages containing pathogenic microorganisms, toxins, or chemical substances, examples of which include listeriosis, viral gastroenteritis, taeniasis, and trichinosis. The escalation in foodborne incidents stems from various factors, such as shifts in food production, distribution, and consumption methods, inadequate food safety measures, and the effects of climate change on food production. Gastrointestinal testing plays a crucial role by identifying the specific pathogens causing these illnesses, thereby assisting healthcare providers in diagnosing the source of gastrointestinal symptoms, determining suitable treatments, tracking outbreaks, and implementing preventative measures to curb the spread of foodborne diseases. For instance, in September 2025, the Centers for Disease Control and Prevention (CDC), a US-based federal public health agency, reported that throughout 2023, the CDC, in collaboration with state and regulatory public health partners, investigated 181 potential multistate outbreaks, of which 84 were confirmed as outbreaks. Among these, investigators successfully solved 50 outbreaks (60%). A suspected source was identified for 22 outbreaks, and a confirmed source was identified for 28 outbreaks. Consequently, the rising frequency of foodborne diseases is fueling the growth of the gastrointestinal pathogen testing market. The escalating antimicrobial resistance is projected to propel the growth of the gastrointestinal pathogen testing market moving forward. Antimicrobial resistance signifies the capacity of bacteria, viruses, and other microorganisms to withstand the effects of drugs that were previously effective against them. The demand for gastrointestinal pathogen testing is on the rise due to the increasing prevalence of drug-resistant gastrointestinal infections, necessitating rapid and precise detection to guide effective treatment and prevent further dissemination. For instance, in October 2025, the World Health Organization, a Switzerland-based specialized agency of the United Nations, reported a global analysis of antibiotic resistance prevalence and trends, drawing upon over 23 million bacteriologically confirmed cases of bloodstream infections, urinary tract infections, gastrointestinal infections, and urogenital gonorrhea. Data for this analysis were submitted by 104 countries in 2023. Therefore, increasing antimicrobial resistance is expected to stimulate the gastrointestinal pathogen testing market.
How Is Segmentation Applied In The Gastrointestinal Pathogen Testing Market Segment Analysis?
The gastrointestinal pathogen testing market covered in this report is segmented –
1) By Pathogen Type: Bacteria, Viruses, Parasites
2) By Test Type: Molecular Tests, Culture, Biochemical Tests, Other Test Types
3) By Panel Type: Syndromic Full Multiplex Panels, Other Panel Types
4) By End-User: Hospitals, Diagnostic Laboratories, Point-Of-Care, Other End Users
Subsegments:
1) By Bacteria: Salmonella spp., Escherichia coli, Campylobacter spp., Shigella spp., Clostridium difficile, Vibrio spp., Listeria monocytogenes, Helicobacter pylori, Other Bacterial Pathogens
2) By Viruses: Norovirus, Rotavirus, Enteric Adenovirus, Hepatitis A Virus (HAV), Astrovirus, Other Viral Pathogens
3) By Parasites: Giardia lamblia, Entamoeba histolytica, Cryptosporidium spp., Trichinella spp., Toxoplasma gondii, Other Parasitic Pathogens
Which Trends Are Guiding The Direction Of The Gastrointestinal Pathogen Testing Market?
Major companies in the gastrointestinal pathogen testing market are focused on developing advanced solutions, such as metagenomic diagnostic tests, to enhance the accuracy, speed, and comprehensiveness of detecting gastrointestinal pathogens. A metagenomic diagnostic test is a cutting-edge technology used to analyze the genetic material of microorganisms present in samples like stool or blood. For instance, in April 2024, Microba Life Sciences, an Australia-based biotechnology company, unveiled MetaPanel, a metagenomic diagnostic test designed to identify a broad spectrum of gastrointestinal pathogens with exceptional accuracy. MetaPanel covers 175 pathogen targets in a single test, offering healthcare professionals a thorough solution for diagnosing both common and difficult-to-detect infections. It employs next-generation sequencing (NGS) technology to analyze a wide range of genetic material within a stool sample. This enables the detection of a diverse variety of potential pathogens, including those not routinely screened for in traditional GI (gastrointestinal) panels.
Who Are The Companies Participating In The Gastrointestinal Pathogen Testing Market Environment?
Major companies operating in the gastrointestinal pathogen testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Becton Dickinson and Company, Hologic Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Cepheid Inc., OraSure Technologies Inc., BioFire Diagnostics Inc., Luminex Corporation, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ELITechGroup S.A.S., Hardy Diagnostics LLC, Trinity Biotech plc, R-Biopharm AG, COPAN Diagnostics Inc., Savyon Diagnostics Ltd., ZeptoMetrix Corporation, Biomerica Inc., Pro-Lab Diagnostics
Get The Full Gastrointestinal Pathogen Testing Market Report:
Which Region Dominates The Gastrointestinal Pathogen Testing Market By Market Share?
North America was the largest region in the gastrointestinal pathogen testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal pathogen testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Gastrointestinal Pathogen Testing Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Gastrointestinal Pathogen Testing Market 2026, By The Business Research Company
Food Pathogen Safety Testing Equipment And Supplies Market Report 2026
Food Pathogen Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/food-pathogen-testing-global-market-report
Infectious Disease Diagnostics Testing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
